Gottlieb Resigns from FDA

December 15, 2006
Pharmaceutical Technology Editors
ePT--the Electronic Newsletter of Pharmaceutical Technology

Dec. 11, 2006 (Rockville, MD)-Effective Jan. 16, 2007, Scott Gottlieb, MD, deputy commissioner for medical and scientific affairs at the US Food and Drug Administration, will leave the agency and will return to the American Enterprise Institute.

Gottlieb Resigns from FDA

Rockville, MD (Dec. 11)-Effective Jan. 16, 2007, Scott Gottlieb, MD, deputy commissioner for medical and scientific affairs at the US Food and Drug Administration (www.fda.gov), will leave the agency and return to the American Enterprise Institute (AEI, Washington, DC, www.aei.org). Before coming to FDA in July 2005, Gottlieb was a resident fellow at AEI.

During his time at FDA, Gottlieb worked on several policy initiatives such as improving the advisory-committee process and communicating risk information to the public more effectively. In addition, Gottlieb helped to implement new regulations and policies such as the new drug and biologic products labeling rule.

This announcement was made shortly after the US Senate confimed Andrew von Eschenbach as the new FDA commissioner (see "Von Eschenbach Confirmed as FDA Commissioner").